Clinical Trial Update: Expanded Access to ABBV-787

View source ↗

Summary

Expanded access to ABBV-787 for Acute myeloid leukemia has been terminated. It is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ABBV-787

Snippet

Sponsor: AbbVie | Conditions: Acute Myeloid Leukemia | Status: NO_LONGER_AVAILABLE